chitosan has been researched along with naringenin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 5 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, HM; Long, YQ; Wang, CY; Yuan, P; Zhang, LK | 1 |
| Birundha, K; Devi, KT; Kaveri, K; Kumar, SP | 1 |
| Bai, Y; Hu, W; Liu, X; Zhang, L; Zhang, P | 1 |
| Chakraborti, AS; Kundu, PP; Maity, S; Mukhopadhyay, P | 1 |
| Begum, KMMS; George, D; Maheswari, PU | 1 |
| Goycoolea, FM; Hensel, A; Nguyen, HT | 1 |
| Cunha-Filho, M; Gelfuso, GM; Gratieri, T; Hilgert, LA; Quintão, WSC; Saldanha-Araújo, F; Silva-Carvalho, AE | 1 |
| Cui, SW; Li, J; Liu, R; Wang, B; Wang, H; Wang, J; Wang, S; Yang, X; Zhang, H; Zhang, N | 1 |
| Dharshene, K; Ganesh, MR; Jaganathan, MK; Ramya Devi, KT | 1 |
9 other study(ies) available for chitosan and naringenin
| Article | Year |
|---|---|
[Study on intra-gastric floating beads of naringenin].
Topics: Alginates; Calcium Chloride; Chitosan; Delayed-Action Preparations; Drug Carriers; Flavanones; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Microspheres; Particle Size; Polypropylenes; Solubility; Technology, Pharmaceutical | 2011 |
Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Topics: Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Chitosan; Drug Compounding; Drug Liberation; Flavanones; Humans; Lung Neoplasms; Mice; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared | 2015 |
Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Topics: Administration, Topical; Animals; beta-Cyclodextrins; Chitosan; Drug Carriers; Drug Liberation; Female; Flavanones; Macular Degeneration; Male; Nanoparticles; Particle Size; Rabbits; Solubility | 2016 |
Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-An in vitro and in vivo approach.
Topics: Administration, Oral; Alginates; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Flavanones; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Particle Size; Rats | 2017 |
Chitosan-cellulose hydrogel conjugated with L-histidine and zinc oxide nanoparticles for sustained drug delivery: Kinetics and in-vitro biological studies.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cell Line, Tumor; Cellulose; Chitosan; Curcumin; Drug Carriers; Drug Liberation; Flavanones; Histidine; Humans; Hydrogels; Kinetics; Metal Nanoparticles; Mice; Quercetin; Staphylococcus aureus; Trichophyton; Zinc Oxide | 2020 |
Chitosan/cyclodextrin surface-adsorbed naringenin-loaded nanocapsules enhance bacterial quorum quenching and anti-biofilm activities.
Topics: Anti-Bacterial Agents; Biofilms; Caco-2 Cells; Chitosan; Cyclodextrins; Escherichia coli; Flavanones; Humans; Nanocapsules; Pseudomonas aeruginosa; Quorum Sensing | 2022 |
Anti-inflammatory effect evaluation of naringenin and its incorporation into a chitosan-based film for transdermal delivery.
Topics: Administration, Cutaneous; Animals; Chitosan; Drug Delivery Systems; Flavanones; Interleukin-10; Leukocytes, Mononuclear; Pharmaceutical Preparations; Skin; Swine; Transforming Growth Factor beta1 | 2022 |
Fabrication, characterization, and lipid-lowering effects of naringenin-zein-sodium caseinate-galactosylated chitosan nanoparticles.
Topics: Animals; Caseins; Chitosan; Cholesterol; Drug Carriers; Lipids; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Triglycerides; Zein | 2023 |
Chitosan-encapsulated naringenin promotes ROS mediated through the activation of executioner caspase-3.
Topics: Antineoplastic Agents; Caspase 3; Chitosan; Humans; Nanoparticles; Reactive Oxygen Species | 2023 |